StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) in a research note issued on Friday. The brokerage set a “sell” rating on the basic materials company’s stock.
Arcadia Biosciences Trading Down 21.0 %
Shares of NASDAQ RKDA opened at $4.64 on Friday. The company’s 50-day moving average price is $4.68 and its 200 day moving average price is $3.60. Arcadia Biosciences has a 52 week low of $1.85 and a 52 week high of $10.31. The stock has a market cap of $6.33 million, a price-to-earnings ratio of -1.08 and a beta of 0.90.
Arcadia Biosciences Company Profile
Recommended Stories
- Five stocks we like better than Arcadia Biosciences
- How to Find Undervalued Stocks
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.